Ciphergen forms blood disorder test deal
This article was originally published in Clinica
Executive Summary
Ciphergen Biosystems and Ohio State University Research Foundation (OSURF) in the US have teamed up to develop and clinically validate a test for the haematologic disease, thrombotic thrombocytopoenic purpura (TTP).